Brief: RenovoRx Announces $11.1 Mln At Market Private Placement
08/04/2024 13:39
April 8 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES $11.1 MILLION AT MARKET PRIVATE
PLACEMENT
* RENOVORX INC - CASH POSITION NOW EXPECTED TO FUND CURRENT
OPERATING PLAN INTO 2026
* RENOVORX INC - PROCEEDS FROM FINANCING ARE ALSO EXPECTED
TO
ENABLE EXPANSION OF TAMP CLINICAL DEVELOPMENT PIPELINE INTO
ADDITIONAL CANCER INDICATIONS
Source text for Eikon: ID:nBw24w2Wxa
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer